| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 01/31/2006 | US6992078 Solvent extraction, separation, crystallization |
| 01/31/2006 | US6992044 Substituted phenyluracils |
| 01/31/2006 | CA2150806C Antiallergic triazolobenzazepine derivatives |
| 01/31/2006 | CA2149924C Use of phenserine to treat cognitive disorders |
| 01/26/2006 | WO2006009655A1 Diphenylimidazopyrimidine and -imidazole amines as inhibitors of b-secretase |
| 01/26/2006 | WO2006008493A1 Synthesis of polyhydroxylated alkaloids |
| 01/26/2006 | WO2005120573A3 Cationic bacteriochlorophyll derivatives and uses thereof |
| 01/26/2006 | WO2005111020A3 Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by vla-4 |
| 01/26/2006 | WO2005110982A3 Substituted 1-benzyl-4-substituted piperazine analogues |
| 01/26/2006 | WO2005079868A3 Crf receptor antagonists, their preparations, their pharmaceutical composition and their uses |
| 01/26/2006 | WO2004096798A3 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokine antagonists |
| 01/26/2006 | US20060020149 Oxidizing cycloalkane with molecular oxygen in the presence of a mixture of metal oxides and/or a composite metal oxide, each containing ruthenium and cobalt as the metal elements therein; excellent selectivity |
| 01/26/2006 | US20060020129 U-oxo crosslinked dissimilar metal phthalocyanine compound and process for selectively producing the same |
| 01/26/2006 | US20060019983 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 01/26/2006 | US20060019982 For therapy of central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 01/26/2006 | US20060019959 Novel quinoxalinone derivatives |
| 01/26/2006 | US20060019957 Imidazotriazines as protein kinase inhibitors |
| 01/26/2006 | US20060019945 Granzyme b inhibitors |
| 01/26/2006 | US20060019939 Analogs of benzoquinone-containing ansamycins and methods of use thereof |
| 01/26/2006 | US20060019928 (Hetero)arylamino-substituted tricyclic pyrrolopyrrolotriazine compounds, used for treating adult respiratory distress syndrome, chronic obstructive pulmonary disease, chronic pulmonary inflammatory disease, solid organ transplant rejection, atherosclerosis, and arthritis |
| 01/26/2006 | DE102004033312A1 Kontinuierliches Metatheseverfahren mit Ruthenium-Katalysatoren Continuous metathesis with ruthenium catalysts |
| 01/26/2006 | CA2578600A1 Diphenylimidazopyrimidine and -imidazole amines as inhibitors of b-secretase |
| 01/26/2006 | CA2574217A1 Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient |
| 01/26/2006 | CA2570968A1 Gonadotropin releasing hormone receptor antagonists |
| 01/25/2006 | EP1618380A2 N epsilon AND/OR N alpha DERIVATIZED, METAL AND ORGANIC PROTECTED L-HISTIDINE FOR COUPLING TO BIOMOLECULES FOR HIGHLY EFFICIENT LABELING WITH (M(OH2)3(CO)3)+ BY FAC COORDINATION |
| 01/25/2006 | EP1618109A2 Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosine receptor antagonists |
| 01/25/2006 | EP1618108A2 Triazolo[1,5-a]pyrimidines and pyrazolo[1,5-a]pyrimidines useful as a2a adenosine receptor antagonists |
| 01/25/2006 | EP1618107A1 Condensed n-heterocyclic compounds and their use as crf receptor antagonists |
| 01/25/2006 | EP1617848A2 Anti-cancer phosphonate conjugates |
| 01/25/2006 | EP1617806A2 Selective spirocyclic glucocorticoid receptor modulators |
| 01/25/2006 | EP1127265A4 Method for non-invasive imaging oxygen distribution in multi-dimensions and apparatus therefor |
| 01/25/2006 | CN1726603A Charge transport compositions and electronic devices made with such compositions |
| 01/25/2006 | CN1726218A Pyrrolopyrimidine derivatives |
| 01/25/2006 | CN1726217A Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 01/25/2006 | CN1726216A C-6 modified indazolylpyrrolotriazines |
| 01/25/2006 | CN1726212A Pre-organized tricyclic integrase inhibitor compounds |
| 01/25/2006 | CN1726201A Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 01/25/2006 | CN1724534A Metal aza porphyrin compound containing fluorene diaryl ethylene and its preparation method and application |
| 01/25/2006 | CN1238355C Metalloporphyrin synthesizing method |
| 01/24/2006 | US6989452 Anticancer agents |
| 01/24/2006 | US6989443 Carboranylporphyrins and uses thereof |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/24/2006 | US6989362 Methods of treating dopamine dysregulation using agents that regulate phosphorylation/dephosphorylation in dopamine signaling |
| 01/24/2006 | CA2209775C Analogues of n-acetylardeemin, method of preparation and uses thereof |
| 01/24/2006 | CA2123093C Sulfonamide herbicides |
| 01/19/2006 | WO2006007378A2 Pyrrolotriazine kinase inhibitors |
| 01/19/2006 | WO2006005726A2 Heterocyclic compounds |
| 01/19/2006 | WO2006005608A1 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha.7-nachr ligands for the treatment of cns diseases |
| 01/19/2006 | WO2006005507A2 Pharmaceutical composition of piperazine derivatives |
| 01/19/2006 | WO2006005492A1 Substituted 6-phenyl-7-amino-triazolopyrimidines, method for the production thereof, their use for controlling pathogenic fungi, and agents containing these compounds |
| 01/19/2006 | WO2005105805A9 Annelated carbamoylase-heterocycles, focused library, pharmaceutical compositions and methods for the production thereof |
| 01/19/2006 | WO2005095357A3 Pyrimidine derivatives and methods of treatment related to the use thereof |
| 01/19/2006 | US20060014953 7-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-2-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4]triazolo[1,5- alpha ]pyrazine, hydrochloride; antidiabetic agent, non-insulin dependent diabetes; synergistic mixture with other active ingredients |
| 01/19/2006 | US20060014950 Combining a strong base with a phenyl isonicotinamide in aprotic solvents to form a solutions, then reacting with a cyclohexanone carboxylic acid or ester and water, and acidifying the solution to obtain chemical intermediates for neuropeptide Y antagonists used for treating bulimia, obesity or diabetes |
| 01/19/2006 | US20060014836 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea;viricides; hepatitis virus |
| 01/19/2006 | US20060014769 Spirohydantoin compounds and methods for the modulation of chemokine receptor activity |
| 01/19/2006 | US20060014767 Heterocyclic antiviral compounds |
| 01/19/2006 | US20060014765 For therapy of, for example, transplant rejection, inflammatory bowel syndrome, rheumatoid arthritis, psoriasis, restenosis, allergic asthma, Alzheimer's disease, Parkinson, stroke, osteoporosis, cancer, and benign hyperplasia |
| 01/19/2006 | US20060014764 Immunosuppressants; autoimmune diseases; antiinflammatory agents;antiarthritic agents; aids |
| 01/19/2006 | US20060014762 2-Pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydoimidazo[1,2-A]pyrimidin-5(1H)one derivatives |
| 01/19/2006 | US20060014756 Benzimidazoles |
| 01/19/2006 | US20060014754 Methods and compositions for treating diseases and conditions of the eye |
| 01/19/2006 | US20060014749 (R)-2-{4-[(1H-Indol-2-ylmethyl)-amino]-piperidin-1-yl}-1-(6-methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria |
| 01/19/2006 | US20060014748 2-NH-heteroarylimidazoles with antibacterial activity |
| 01/19/2006 | US20060014746 Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands |
| 01/19/2006 | US20060014745 Pyrrolotriazine compounds |
| 01/19/2006 | US20060014744 Midazopyrazinones and imidazotriazinones derivates as gaba-a receptor anxiolytic |
| 01/19/2006 | US20060014741 Synthetic process, and crystalline forms of a pyrrolotriazine compound |
| 01/19/2006 | US20060014739 Androgen receptor modulators and method of treating disease using the same |
| 01/19/2006 | US20060013860 Anticancer agents; side effect reduction |
| 01/19/2006 | US20060013774 Porphyrin compounds and their use in high-field MRI |
| 01/19/2006 | DE60110592T2 Pharmazeutische zusammensetzung enthaltend ein farnesyl-transferase hemmenden 1,2-annellierten chinolin enantiomer A pharmaceutical composition comprising a farnesyl transferase inhibitory 1,2-annelated quinoline enantiomer |
| 01/19/2006 | DE102004031656A1 Tetrahydrochinoline Tetrahydroquinolines |
| 01/19/2006 | CA2570155A1 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha.7-nachr ligands for the treatment of cns diseases |
| 01/18/2006 | EP1616871A1 Porphyrin compound containing biotinyl group and use thereof |
| 01/18/2006 | EP1616870A1 Fungicidal triazolopyrimidines, process for their preparation, their use for combatting fungi and agents comprising them |
| 01/18/2006 | EP1616869A1 Substituted porphyrins and their therapeutic use |
| 01/18/2006 | EP1615949A1 Process for the preparation of macrocyclic compounds by ruthenium complex catalysed metathesis reaction |
| 01/18/2006 | EP1615931A1 Triazolopyrazines and methods of making and using the same |
| 01/18/2006 | EP1615930A2 Triazolotriazines and pyrazolotriazines useful as a2a adenosine receptor antagonists |
| 01/18/2006 | EP1615929A1 Pyrrolo [1,2-b] pyridazine compounds and their uses |
| 01/18/2006 | EP1615928A1 Pyrimido compounds |
| 01/18/2006 | EP1615886A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions |
| 01/18/2006 | EP1615647A2 Pharmaceutical use of fused 1,2,4-triazoles |
| 01/18/2006 | EP1615613A2 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors |
| 01/18/2006 | EP1615552A2 Sapphyrins and uses thereof |
| 01/18/2006 | EP1207161B1 Novel isoindole derivatives |
| 01/18/2006 | EP0954308B1 Therapeutic treatment for cardiovascular diseases |
| 01/18/2006 | CN1723207A Inhibitors of histone deacetylase |
| 01/18/2006 | CN1237061C Chemokine receptor binding heterocyclic compounds |
| 01/18/2006 | CN1237060C Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists |
| 01/17/2006 | US6987190 Reacting glyoxal and urea; sustained release fertilizer |
| 01/17/2006 | US6987187 Process for preparation of amidine derivatives |
| 01/17/2006 | US6987113 3-hetero-arylideneazaindolin-2-one compounds |
| 01/17/2006 | US6987108 Pharmaceutical formulations of antineoplastic agents and processes of making and using the same |
| 01/17/2006 | US6987106 Nootropic agents; Alzheimer's Disease, Schizophrenia; ligands for the a7 subunits of the nicotinic receptor; 4-Bromophenyl-1,4-diazabicyclo[3.2.2]nonane-4-carboxylate |
| 01/17/2006 | US6987102 Methods to mobilize progenitor/stem cells |
| 01/12/2006 | WO2006004937A2 Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders |
| 01/12/2006 | WO2006004931A2 Substituted azepine derivatives as serotonin receptor modulators |
| 01/12/2006 | WO2006004884A2 Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |